IMUX : Insider Transactions for Immunic Inc

Company Profile Immunic is a clinical-stage biopharmaceutical company. Co. is pursuing three development programs. These include the vidofludimus calcium (IMU-838) program, which is focused on the development of oral formulations of a small molecule inhibitor of the enzyme dihydroorotate dehydrogenase; the IMU-935 program, which is focused on an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated, an immune cell-specific isoform of retinoic acid receptor-related orphan nuclear receptor gamma; and the IMU-856 program, which involves the development of a drug targeting the restoration of intestinal barrier function and regeneration of bowel epithelium.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	14,000	14,000	14,000	122,500
Total Buy Value	$18,333	$18,333	$18,333	$174,157
Total People Bought	1	1	1	3
Total Buy Transactions	1	1	1	8
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-18	2023-11-17	2023-05-19	2022-05-19

Adjust Filter Settings

Records found: 113

Page 2 of 5

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Nash Duane

Director

– • –

2019-12-04

$6.96

$30,624

D/D

(4,400)

10,032

Nash Duane

Director

– • –

2019-12-03

$7.15

$56,732

D/D

(7,930)

14,432

Nash Duane

Director

– • –

2019-12-02

$0.00

D/D

22,157

22,362

Halperin Errol R.

Director

– • –

2018-09-25

$0.29

$2,900

I/I

(10,000)

Halperin Errol R.

Director

– • –

2018-09-25

$0.29

$25,940

D/D

(89,417)

Bienaime Jean Jacques

Director

– • –

2018-09-24

$0.30

$8,002

D/D

(26,619)

18,500

Godshall Douglas Evan

Director

– • –

2018-09-19

$0.35

$24,191

D/D

(69,375)

Satter Muneer A

Director

– • •

2018-09-17

$0.29

$2,054,257

I/I

(7,044,777)

Satter Muneer A

Director

– • •

2018-09-14

$0.36

$160,384

I/I

(447,500)

7,044,777

Satter Muneer A

Director

– • •

2018-09-13

$0.50

$1,930,996

I/I

(3,890,000)

7,492,277

Hasnain Faheem

Director

– • –

2018-09-13

$0.44

$77,679

D/D

(177,443)

4,500

Bienaime Jean Jacques

Director

– • –

2018-09-13

$0.47

$9,400

D/D

(20,000)

45,119

Cohen Cheryl

Director

– • –

2018-09-12

$0.55

$1,925

I/I

(3,500)

Satter Muneer A

Director

– • •

2017-12-13

$5.57

$278,570

I/I

50,000

11,382,277

2.25

Satter Muneer A

Director

– • •

2017-12-12

$5.40

$269,765

I/I

50,000

11,332,277

2.25

Satter Muneer A

Director

– • •

2017-12-11

$4.96

$248,225

I/I

50,000

11,282,277

2.25

Satter Muneer A

Director

– • •

2017-12-08

$4.92

$246,185

I/I

50,000

11,232,277

2.25

Satter Muneer A

Director

– • •

2017-12-07

$4.77

$238,730

I/I

50,000

11,182,277

2.25

Hasnain Faheem

Director

– • –

2017-09-14

$4.19

$247,870

D/D

59,200

181,943

2.39

Satter Muneer A

Director

– • •

2017-09-14

$4.25

$127,539

I/I

30,000

11,132,277

2.25

Satter Muneer A

Director

– • •

2017-09-13

$4.13

$206,465

I/I

50,000

11,102,277

2.25

Satter Muneer A

Director

– • •

2017-09-12

$3.74

$187,225

I/I

50,000

11,052,277

2.25

Satter Muneer A

Director

– • •

2017-09-08

$3.53

$176,615

I/I

50,000

11,002,277

2.25

Dunn John Michael

General Counsel and Secretary

• – –

2017-06-14

$3.08

$7,724

D/D

2,500

11,885

2.74

Winters Terence E.

Co-Chairman and CEO

• • –

2017-06-14

$3.10

$30,981

D/D

10,000

194,966

2.81

113 Records found	1 2 3 4 5	Page 2 of 5

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: